Ashley Brannon

Ashley Brannon has a strong background in pharmacovigilance, with experience in various roles at different companies. Ashley is currently the Director of Operations, Pharmacovigilance at Akebia Therapeutics, a position they have held since February 2021. Prior to that, they worked as the Associate Director of Operations, Pharmacovigilance at Akebia Therapeutics from April 2019 to February 2021. Before joining Akebia Therapeutics, Ashley was a Pharmacovigilance Manager at Keryx Biopharmaceuticals from December 2018 to April 2019. At Keryx Biopharmaceuticals, they also held the position of Pharmacovigilance Manager from March 2017 to December 2018. Before that, Ashley worked as a Pharmacovigilance Quality and Operations Specialist at Keryx Biopharmaceuticals from March 2015 to March 2017. Prior to their roles in the pharmaceutical industry, Ashley gained experience in healthcare by working as a Pharmacovigilance Operations Specialist and a Drug Safety Coordinator at ARIAD Pharmaceuticals, Inc. from December 2011 to March 2015. Ashley also held the position of Fellowship Coordinator - Pediatric GI & Nutrition at Massachusetts General Hospital from July 2009 to December 2011. Ashley's earliest work experience was as a Staff Assistant/Research at CentraState Healthcare System from June 2005 to September 2009.

From 2005 to 2009, Ashley Brannon attended Boston University, where they earned a Bachelor of Arts degree in Psychology with a focus on Pre-Med.